Cumberland Pharmaceuticals Inc share price logo

Cumberland Pharmaceuticals Inc Share Price

NASDAQ: CPIX

Small Cap

$3.22

-0.03

(-0.92%)

Live

as on

Cumberland Pharmaceuticals Inc Stock Performance

as on April 2, 2026 at 4:04 am IST

  • Day's Low

    Day's High

    $3.16
    $3.33
    downward going graph

    1.86%

    Downside

    3.42%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.85
    $6.27
    downward going graph

    42.55%

    Downside

    94.57%

    Upside

    downward going graph

Cumberland Pharmaceuticals Inc share price movements today

Previous Close
$3.25
Open
$3.29
Volume
127.4K
Day's Low - High
$3.16 - $3.33
52 Week Low - High
$1.85 - $6.27

Cumberland Pharmaceuticals Inc Historical Returns

1 Month Return
-33.94 %
3 Month Return
-18.34 %
1 Year Return
-25.46 %
3 Year Return
+ 66.67 %
5 Year Return
+ 5.86 %

Cumberland Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Cumberland Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$46.7M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.85

Industry PE ratio

0

PEG Ratio

1.6667

EBITDA

1.4M

Revenue (TTM)

44.5M

Profit Margin

-6.37%

Return On Equity TTM

-12.17%

Cumberland Pharmaceuticals Inc Stock Valuation

Track how Cumberland Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Cumberland Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (-39.63x)

March 31, 2023

Industry (0.00x)

April 1, 2026

Today (-1.85x)

April 1, 2026

Highest (33.00x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -1.85x

Cumberland Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cumberland Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Cumberland Pharmaceuticals Inc image
Cumberland Pharmaceuticals Inc
SELL$46.7M5.86%-1.85-6.37%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$26.0BNA21.2841.94%
Viatris Inc. image
Viatris Inc.
HOLD$14.9B-2.81%-21.95-24.58%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$44.6BNA20.4115.11%
Zoetis Inc. image
Zoetis Inc.
BUY$51.3B-25.13%19.3628.24%

Stock Returns calculator for Cumberland Pharmaceuticals Inc Stock including INR - Dollar returns

The Cumberland Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cumberland Pharmaceuticals Inc investment value today

Current value as on today

₹80,511

Returns

-₹19,489

(-19.49%)

Returns from Cumberland Pharmaceuticals Inc Stock

-₹26,147 (-26.15%)

Dollar Impact

₹6,658 (+6.66%)

Analyst Recommendation on Cumberland Pharmaceuticals Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Cumberland Pharmaceuticals Inc. Average target price of $8.5

Cumberland Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Cumberland Pharmaceuticals Inc.

What analysts predicted

62.12%UPSIDE

Target Price

$8.5

Current Price

$3.22

Analyzed by

6 Analysts

Target

$8.50

Cumberland Pharmaceuticals Inc target price $8.5, a slight upside of 62.12% compared to current price of $3.22. According to 6 analysts rating.

Cumberland Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Cumberland Pharmaceuticals Inc Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-15% versus previous 30 day period

Cumberland Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
10
9
8
9
9
10
11
10
8
13
Gross Profit
8
7
6
8
7
8
10
8
7
11
Operating Income
-1
-6
-1
-1
-1
-1
1
0
-1
-1
EBITDA
0
-4
0
0
0
0
2
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
2
1
1
1
1
1
1
1
1
Income Before Tax
-1
-6
-1
-1
-1
-1
1
0
-1
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-1
-6
-1
-1
-1
-1
1
0
-1
-1
Net Profit Margin
-10.40%
-67.30%
-22.90%
-11.02%
-16.99%
-18.24%
10.73%
-6.84%
-23.40%
-10.32%

Cumberland Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
33
41
40
34
37
35
42
39
37
44
Gross Profit
27
33
33
26
28
27
32
33
31
37
Operating Income
-1
-4
-7
-9
-6
-7
-5
-9
-6
-2
EBITDA
1
-1
-8
-4
-1
0
0
2
0
2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
2
2
4
4
4
5
4
6
5
Income Before Tax
-1
-3
-7
-9
-6
-5
-5
-6
-6
-2
Income Tax Expense
0
4
0
0
0
0
0
0
0
0
Net Income
0
-7
-6
-3
-3
-3
-5
-6
-6
-2
Net Profit Margin
-2.86%
-19.39%
-17.09%
-10.29%
-8.92%
-9.75%
-13.26%
-15.88%
-17.11%
-6.37%

Cumberland Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-1
-1
-1
-1
1
0
-1
-1
Operating Cash Flow
1
-2
0
0
1
3
0
0
0
Investing Cash Flow
0
0
0
0
0
-1
0
0
-3
Financing Cash Flow
-1
2
0
0
-1
-5
0
0
0
Change in Cash
0
0
-1
0
0
-2
0
0
-3

Cumberland Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-8
-7
-3
-3
-3
-5
-6
-6
-2
Operating Cash Flow
0
3
3
5
6
8
6
0
4
Investing Cash Flow
9
-27
2
-1
0
-13
0
0
-4
Financing Cash Flow
1
7
-5
-7
-3
-2
-7
0
-6
Change in Cash
10
-17
0
-3
2
-7
-1
0
-6

Global Institutional Holdings in Cumberland Pharmaceuticals Inc

Funds
Holdings
Dimensional Fund Advisors, Inc.
1.8%
BOOTHBAY FUND MANAGEMENT, LLC
0.85%
Susquehanna International Group, LLP
0.08%
Citadel Advisors Llc
0.28%
Group One Trading, LP
0.05%
See all

Insights on Cumberland Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 8.29M → 13.67M (in $), with an average increase of 39.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -1.94M → -1.41M (in $), with an average increase of 37.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 164.8% return, outperforming this stock by 98.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 93.2% return, outperforming this stock by 118.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, CPIX stock has moved down by -33.9%

About Cumberland Pharmaceuticals Inc

cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.
OrganisationCumberland Pharmaceuticals Inc
Headquarters1600 West End Avenue, Nashville, TN, United States, 37203
IndustryHealth Technology
CEOMr. A. J. Kazimi MBA
E-voting on sharesClick here to vote

Key Management of Cumberland Pharmaceuticals Inc

Name

Title

Mr. A. J. Kazimi MBA

Founder, Chairman, President & CEO

Mr. John Michael Hamm C.M.A.

Vice President Accounting & Finance and CFO

Mr. James Lowrance Herman

VP of Trade & Distribution and Chief Compliance Officer

Mr. Christopher T. Bitterman

Vice President of Sales & Marketing

Mr. Todd M. Anthony

Vice President of Organizational Development

Ms. Jean W. Marstiller

Senior VP of Administrative Services & Corporate Secretary

FAQs

What is Cumberland Pharmaceuticals Inc share price today?

Cumberland Pharmaceuticals Inc share price today is $3.22 as on . Cumberland Pharmaceuticals Inc share today touched a day high of $3.33 and a low of $3.16.

What is the 52 week high and 52 week low for Cumberland Pharmaceuticals Inc share?

Cumberland Pharmaceuticals Inc share touched a 52 week high of $6.27 on and a 52 week low of $1.85 on . Cumberland Pharmaceuticals Inc stock price today i.e. is trending at $3.22,which is 48.60% down from its 52 week high and 74.05% up from its 52 week low.

What is Cumberland Pharmaceuticals Inc's market capitalisation today?

Cumberland Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Cumberland Pharmaceuticals Inc Stock (CPIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cumberland Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cumberland Pharmaceuticals Inc Shares that will get you 0.4658 shares as per Cumberland Pharmaceuticals Inc share price of $3.22 per share as on April 1, 2026 at 10:34 pm IST.

What is the minimum amount required to buy Cumberland Pharmaceuticals Inc Stock (CPIX) from India?

Indian investors can start investing in Cumberland Pharmaceuticals Inc (CPIX) shares with as little as ₹93.295 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.95 in Cumberland Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cumberland Pharmaceuticals Inc share’s latest price of $3.22 as on April 1, 2026 at 10:34 pm IST, you will get 3.1056 shares of Cumberland Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Cumberland Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Cumberland Pharmaceuticals Inc stock has given 5.86% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?